These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 3215245)
1. Intracavernous self-injection for erectile failure. Ruutu M; Lindström BL; Virtanen J; Alfthan O Eur Urol; 1988; 15(1-2):96-8. PubMed ID: 3215245 [TBL] [Abstract][Full Text] [Related]
2. [Intracavernous pharmacotherapy for treatment and evaluation of impotence]. Vardi Y; Lidgi S; Moskovitz B; Levin RD Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307 [TBL] [Abstract][Full Text] [Related]
3. [Intracavernous injection of vasoactive drugs for treating erectile impotence]. Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019 [TBL] [Abstract][Full Text] [Related]
4. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients. Sidi AA; Cameron JS; Duffy LM; Lange PH J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014 [TBL] [Abstract][Full Text] [Related]
5. Classification of sexual dysfunction for management of intracavernous medication-induced erections. Fein RL J Urol; 1990 Feb; 143(2):298-301. PubMed ID: 1688954 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. Lee LM; Stevenson RW; Szasz G J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589 [TBL] [Abstract][Full Text] [Related]
7. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy. Padma-Nathan H; Goldstein I; Krane RJ Semin Urol; 1986 Nov; 4(4):236-8. PubMed ID: 3797893 [No Abstract] [Full Text] [Related]
8. Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents. Kiely EA; Bloom SR; Williams G Br J Urol; 1989 Aug; 64(2):191-4. PubMed ID: 2765789 [TBL] [Abstract][Full Text] [Related]
9. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury. Bodner DR; Lindan R; Leffler E; Kursh ED; Resnick MI J Urol; 1987 Aug; 138(2):310-1. PubMed ID: 3599245 [TBL] [Abstract][Full Text] [Related]
10. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. von Heyden B; Donatucci CF; Kaula N; Lue TF J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018 [TBL] [Abstract][Full Text] [Related]
11. [Intracavernous pharmacotherapy for organic impotence in the elderly]. Richter S; Shalev M; Nissenkorn I Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669 [TBL] [Abstract][Full Text] [Related]
12. Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. Gasser TC; Roach RM; Larsen EH; Madsen PO; Bruskewitz RC J Urol; 1987 Apr; 137(4):678-80. PubMed ID: 3550149 [TBL] [Abstract][Full Text] [Related]
13. [Prostaglandin E1 in erectile dysfunction]. Porst H Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258 [TBL] [Abstract][Full Text] [Related]
15. Impotence: treatment by autoinjection of vasoactive drugs. Williams G; Mulcahy MJ; Kiely EA Br Med J (Clin Res Ed); 1987 Sep; 295(6598):595-6. PubMed ID: 3117249 [TBL] [Abstract][Full Text] [Related]
17. Intracavernosal papaverine and phentolamine for the medical management of erectile dysfunction in a genitourinary clinic. Armstrong DK; Convery A; Dinsmore WW Int J STD AIDS; 1993; 4(4):214-6. PubMed ID: 8399501 [TBL] [Abstract][Full Text] [Related]